ArticleMethods in molecular biology (Clifton, N.J.)2025
A Survey of Current Status in AI-Based Topology Prediction of Transmembrane Proteins.
Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Most of the sequence-based structure prediction and experimental structure determination research have been focused on soluble proteins, with relatively less attention paid to the transmembrane proteins. With the availability of high-quality methods for the structure prediction of the soluble proteins, there is a need to fill the gaps for the prediction of transmembrane proteins, motivated by the fact that they are the primary targets of many drug design efforts. We provide a systematic survey of machine learning methods that predict various aspects of topological properties of transmembrane proteins, including helical and beta-barrel proteins. We reveal that despite a smaller number of unique solved structures for this group of proteins, a battery of corresponding algorithms has been developed. These algorithms offer various degrees of accuracy which needs further improvements. We present a case study to illustrate a typical predictive scenario that shows that the available prediction methods may produce somewhat different results and we discuss how to deal with situations like this.
Indexed as
Identifiers
40728610What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.